siRNA-CTNNB1 targeting to reduce β-catenin expression can inhibit this pathway and decrease the production of target genes cyclin-D1 and GS, impairing the proliferation and survival of HCC cells (246). Here, CTNNB1 is linked to hepatocellular carcinoma.